Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Drug
Medications & Supplements/Prescription Drugs

Belmar Select Outsources Testosterone Pellets Recalled for Glass Particles

Agency Publication Date: May 6, 2025
Share:
Sign in to monitor this recall

Summary

Belmar Select Outsources (BSO LLC) is recalling 8,502 vials of compounded Testosterone Pellets (100 mg and 200 mg) because glass particles were discovered inside the pellet vials. These pellets are intended for subcutaneous use, meaning they are implanted under the skin by a healthcare provider. The recall affects several variations of the pellets, including those with different cholesterol concentrations and those labeled as 'Blunt.'

Risk

The presence of glass fragments in an implantable medication can lead to local irritation, inflammation, or more serious tissue damage at the site of the injection or implantation.

What You Should Do

  1. This recall involves compounded Testosterone Pellets in 100 mg and 200 mg strengths sold under the Belmar Select Outsources brand, including variants with cholesterol (2% or 4%) and 'Blunt' versions.
  2. Affected products are identified by NDC numbers 70168-0101-01, 70168-0125-01, 70168-0124-01, 70168-0122-01, and 70168-0121-01. Check the lot number and expiration date on your vial packaging, such as lot 20250102@6 with expiration 12/11/2025. See the Affected Products section below for the full list of affected codes.
  3. If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact the manufacturer for further instructions.
  4. Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls for more information.

Your Remedy Options

You have 2 options:

๐Ÿ’ฐOption 1: Full Refund
How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund
๐Ÿ—‘๏ธOption 2: Dispose of Product
How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: TESTOSTERONE PELLET 100 mg (with Cholesterol <=4%)
Variants: 100 mg, Subcutaneous Pellet
Lot Numbers:
20250102@6 (Exp 12/11/2025)
20250130@4 (Exp 1/22/2026)
NDC:
70168-0101-01

Compounded Drug, Not for Resale, RX or Office Use Only

Product: TESTOSTERONE PELLET 200 mg (with Cholesterol <=2%)
Variants: 200 mg, Subcutaneous Pellet
Lot Numbers:
20250207@1 (Exp 1/31/2026)
20250228@1 (Exp 1/31/2026)
NDC:
70168-0125-01

Compounded Drug, Not for Resale, RX or Office Use Only

Product: TESTOSTERONE PELLET 200 mg BLUNT (with Cholesterol <=2%)
Variants: 200 mg, Subcutaneous Pellet, Blunt
Lot Numbers:
20250217@7 (Exp 1/31/2026)
NDC:
70168-0124-01

Compounded Drug, Not for Resale, RX or Office Use Only

Product: TESTOSTERONE PELLET 200 mg (with Cholesterol <=4%)
Variants: 200 mg, Subcutaneous Pellet
Lot Numbers:
20250205@6 (Exp 1/30/2026)
NDC:
70168-0122-01

Compounded Drug, Not for Resale, RX or Office Use Only

Product: TESTOSTERONE PELLET 200 mg BLUNT
Variants: 200 mg, Subcutaneous Pellet, Blunt
Lot Numbers:
20250129@1 (Exp 1/17/2026)
20250218@4 (Exp 1/25/2026)
NDC:
70168-0121-01

Compounded Drug, Not for Resale, RX or Office Use Only

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 96792
Status: Active
Manufacturer: BSO LLC
Sold By: Belmar Select Outsources
Manufactured In: United States
Units Affected: 5 products (2,762 vials; 1,974 vials; 355 vials; 1,447 vials; 1,964 vials)
Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.